Concepedia

Oral ibandronic acid versus intravenous zoledronic acid in treatment of bone metastases from breast cancer: a randomised, open label, non-inferiority phase 3 trial

Peter Barrett‐Lee, Angela Casbard, Jacinta Abraham, Kerenza Hood, Robert E. Coleman, Peter Simmonds, Hayley Timmins, Duncan Wheatley, Robert Grieve, Gareth Griffiths,

The Lancet Oncology · 2013 · 127 citations · 12 references

Concepts

Breast OncologyOpen LabelMedicineClinical TrialsBreast CancerPharmacotherapyNon-inferiority Phase 3Cancer TreatmentOncologyRadiation OncologyOsteoporosisOrthopaedic SurgeryHealth Sciences

References

12

Pain assessment: global use of the Brief Pain Inventory.

Cleeland Cs, Ryan Km · PubMed · 1994 · 5.3K citations

Pain Therapy, Brief Pain Inventory, Pain Disorders +15

Cox's Regression Model for Counting Processes: A Large Sample Study

P. Andersen, Richard D. Gill · The Annals of Statistics · 1982 · 4.3K citations

Recurrent Event, Retrospective Cohort Study, Multivariate Analysis +15

Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study

Alison Stopeck, Allan Lipton, Jean-Jacques Body et al. · Journal of Clinical Oncology · 2010 · 1.6K citations

Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial.

Lee S. Rosen, David Gordon, Mary Kaminski et al. · PubMed · 2002 · 899 citations

Long‐term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma

Lee S. Rosen, David Gordon, Mary Kaminski et al. · Cancer · 2003 · 872 citations · Full text